Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Driving performance study of daridorexant in older adults
NCT03892902Phase 1Completed
- Sponsor
- Idorsia
- Start
- Mar 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of daridorexant in Insomnia (4 arms), sponsored by Idorsia. Primary endpoint: Driving performance as measured by the Standard Deviation of Lateral Position (SDLB) at Day 2. Started Mar 2019; status: completed.
02
Drugs
daridorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT03892902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03892902.